IN8bio, Inc.

NASDAQ:INAB

0.2301 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Assets:
Current Assets:
Cash & Cash Equivalents 21.28218.18237.02117.9940.614.99
Short Term Investments 000000
Cash and Short Term Investments 21.28218.18237.02117.9940.614.99
Net Receivables 000000.03
Inventory 000000.015
Other Current Assets 3.3434.0521.9590.150.0480.037
Total Current Assets 24.62522.23438.9818.1440.7635.072
Non-Current Assets:
Property, Plant & Equipment, Net 8.57310.2982.8340.1860.2740.795
Goodwill 000000
Intangible Assets 00.1260000
Goodwill and Intangible Assets 00.1260000
Long Term Investments 0.2560.2520.251000
Tax Assets 0-0.2520000
Other Non-Current Assets 0.2550.3810.1582.580.0930.028
Total Non-Current Assets 9.08410.8053.2432.7660.3670.823
Total Assets 33.70933.03942.22320.911.135.895
Liabilities & Equity:
Current Liabilities:
Account Payables 0.9242.0910.3950.620.560.419
Short Term Debt 1.5141.3890.6260.17400
Tax Payables 000000
Deferred Revenue 000000
Other Current Liabilities 2.9552.3421.2351.7780.0870
Total Current Liabilities 5.3935.8222.2562.5720.6470.419
Non-Current Liabilities:
Long Term Debt 3.3794.4851.784000
Deferred Revenue Non-Current 000000
Deferred Tax Liabilities Non-Current 000000
Other Non-Current Liabilities 0000.0170.8290.829
Total Non-Current Liabilities 3.3794.4851.7840.0170.8290.829
Total Liabilities 8.77210.3074.042.5891.4761.248
Equity:
Preferred Stock 0042.22334.98.8968.896
Common Stock 0.0040.0030.0020.0010.0010.001
Retained Earnings -91.219-61.212-32.691-18.038-9.481-4.347
Accumulated Other Comprehensive Income/Loss 00-42.223000
Other Total Stockholders Equity 116.15283.94170.8721.4580.2380.097
Total Shareholders Equity 24.93722.73238.18318.321-0.3464.647
Total Equity 24.93722.73238.18318.321-0.3464.647
Total Liabilities & Shareholders Equity 33.70933.03942.22320.911.135.895